OBJECTIVE: To compare insulin sensitivity indexes derived from plasma insulin (I) and glucose (G) in the basal state (Sib) and at the second hour (I2h and G2h) of an oral glucose tolerance test (OGTT, Si2h) (i) with measurements of insulin sensitivity using the insulin modi®ed frequently sampled intravenous glucose tolerance test (FSIVGTT) [Si (IVGTT) ] and (ii) with modelling of fasting glucose and insulin by the homeostasis model assessment (HOMA). SUBJECTS: 47 subjects entered the study. 31 subjects were classi®ed as having normal glucose tolerance (NGT), 10 as having impaired tolerance to glucose (IGT) and six as type 2 diabetes mellitus according to the World Health Organisation (WHO) criteria. MEASUREMENTS: Sib and Si2h were calculated as follows. Sib 10 8 a(IÂGÂVD), Si2h 10 8 a(I2hrÂG2hrÂVD) where VD is an estimate of the apparent glucose distribution volume. A third insulin sensitivity index (SiM) was calculated by averaging Sib and Si2h. HOMA was calculated as follows: Ia(22.5Âe 7lnG ) RESULTS: Si (IVGTT) , Sib, SI2h and SiM were all signi®cantly higher in subjects with NGT than in those with IGT or type 2 diabetes. Si (IVGTT) was highly correlated (P 0.0001) with the three insulin sensitivity indexes found in the total population, in subjects with NGT and in those with IGT. In type 2 diabetic patients, a signi®cant correlation was only noted when SiM was tested against Si (IVGTT) (P 0.05). In most circumstances, the associations of Si (IVGTT) with Sib, SI2h and SiM were stronger than the corresponding associations with Ib, I2h or HOMA. SiM was the index that correlated best with Si (IVGTT) in the whole group (r 0.92, P`0.0001) as well as in NGT (r 0.86, P`0.0001), IGT (r 0.96; P`0.0001) and type 2 diabetes (r 0.83, P 0.05) subgroups. CONCLUSIONS: Calculations of sensitivity indexes from G and I concentrations in the basal state and during a conventional 2 h OGTT appear to be useful for coupling in the same simple and single test both a determination of glucose tolerance and an estimate of insulin sensitivity.
Introduction
Obesity is an insulin resistance-state per excellence and is among the ®rst pathologies in which resistance to insulin-mediated glucose uptake has been demonstrated. 1 Insulin resistance is increasingly being recognized as an important factor in the pathogenesis of a number of common diseases, including type 2 diabetes mellitus, 2 ischaemic heart disease 3 and hypertension. 4 It is at the core of the so-called metabolic syndrome, 5 and thus could be responsible for the increased cardiovascular morbidity and mortality of the obese. 6 Many techniques with varying degrees of complexity have been used for estimating the insulin sensitivity of peripheral tissues, but the glucose clamp as described by DeFronzo et al 7 remains the`gold standard'. The glucose clamp uses the rate of glucose infused to maintain plasma glucose at a given level when an hyperinsulinaemic state is created by a sustained insulin infusion at a constant rate. This procedure is time consuming and requires considerable expertise and equipment. The use of computer modelling for glucose and insulin kinetics during a frequently sampled intravenous glucose tolerance test (FSIVGTT) is relatively easier to implement 8 and has been well validated against clamp measures over a wide range of glucose tolerance. 9 ± 12 Although it has been proven that this technique is feasible on such large sample studies as the Insulin Resistance Atherosclerosis Study (IRAS), 13 there remains that a simpli®ed method is required for estimating the insulin sensitivity of the increasing number of obese, 14 especially in large scale epidemiological studies. On the other hand, such simple methods as measurements of the insulin concentrations 15 or of the ratio of insulinto-glucose concentrations (IaG) at fasting, have been widely proposed, for several years, to estimate the magnitude of both insulin secretion and tissue sensitivity to insulin. 16 However, the interpretation of such an index, based on the measurement of two variables, is quite dif®cult, because neither variable can be held constant. In healthy subjects, it has been established that insulin sensitivity times b-cell function is a constant for a given tolerance to glucose. 17 Therefore, in this group of individuals, any change in insulin sensitivity normally results in an inverse variation of the IaG ratio. This relationship disappears 16, 18 and a diminution in the IaG ratio cannot be interpreted as an improvement in insulin sensitivity as soon as the patients suffer from a certain degree of b-cell de®-ciency. 19 It has been demonstrated that increasing hyperglycaemia in type 2 diabetic patients results simultaneously or sequentially from both a progressive reduction in insulin sensitivity and a worsening in insulin secretion. 19, 20 A computer-solved model of insulin:glucose interactions has also been proposed to estimate b-cells de®ciency and insulin resistance (homeostasis model assessment, HOMA), 21 but up to now, the use of the HOMA remains relatively restricted.
Since any decrease in insulin secretion should be compensated, or even`overcompensated', by an increase in plasma glucose concentrations, 20 it is reasonable to postulate that plasma insulin levels times plasma glucose concentration (IÂG) might correlate better than the IaG ratio, and more likely in a negative manner, with the tissue sensitivity to insulin. In order to gain further insight into this problem and considering that the minimal model is known as a well-recognized method for estimating insulin sensitivity, 9 ± 12 we were led to investigate whether measurements of insulin sensitivity (using the insulin-modi®ed FSIVGTT) correlate or not with the inverse of the IÂG product in subjects with normal tolerance to glucose and in patients suffering from impaired glucose tolerance or type 2 diabetes.
Research design and methods
Forty seven subjects consulting at our center for being overweight or for weight gain entered the study. All participants were submitted to an insulin-modi®ed FSIVGTT preceded by an oral glucose tolerance test (OGTT) at a one week-interval during which they were maintained on their usual diet. Thirty one subjects were classi®ed as having normal glucose tolerance (NGT), 10 as impaired tolerance to glucose (IGT) and six as overt type 2 diabetes mellitus (Type 2) according to the World Health Organization (WHO) criteria. 22 The main clinical characteristics and basic laboratory data of the subjects are given in Table 1 . None of these 47 subjects were taking medications known to interfere with glucose metabolism.
On each test day (OGTT, FSIVGTT), all subjects were admitted to the Metabolic Disease Department at 08.00 h after an overnight (12 h) fast and remained at bed rest for the entire period of the tests. All subjects were studied after giving their informed consent to participate in the study.
OGTTs
A 75 g glucose load in 200 ml of water was administered orally over a period`5 min. Blood samples were collected through an indwelling catheter implanted in the cubital vein before ingestion of glucose and at 30 min intervals after the glucose load over a 2 h period. Plasma glucose was measured using the glucose oxidase technique on an automated analyzer (Kodak, Paris, France). Plasma insulin concentrations (I) were measured using a radioimmunoassay (RIA; Cis Bio International, Gil-pun-Yvette, France).
Insulin-modi®ed FSIVGTTs
Antecubital veins were canulated in both arms, one for sampling and the other for administration of glucose and insulin. After basal sampling for glucose and insulin, glucose (300 mgakg) was administered at a constant rate for 2 min from t 0 min. At 20 min, 0.05 Uakg Actrapid (Novo Nordisk, Copenhagen, Denmark) was given as a bolus injection. Blood samples for glucose and insulin were taken at t 715 min, 710 min, 75 min, 0 min, 2 min, 3 min, 4 min, 5 min, 8 min, 10 min, 18 min, 20 min, 28 min, 32 min, 40 min, 60 min, 70 min and 240 min. 23 The insulin and glucose kinetics were modelled using the minimol model, 8 which provides an estimate of insulin sensitivity (Si (IVGTT) ) expressed as 10 4 .min 71 .mU 71 .ml.
Insulin sensitivity estimates derived from plasma insulin and glucose
Two insulin sensitivity indexes were derived from plasma insulin and plasma glucose concentrations in the basal state (Sib) and at the second hour of an OGTT (Si2h): Sib 10 8 a(IÂGÂVD) and Si2h 10 8 a (I2hÂG2hÂVD). G and I were fasting plasma glucose (mgadl) and insulin (mUaml) concentrations, respectively, while G2h and I2h were plasma glucose Insulin, plasma glucose and insulin sensitivity A Avignon et al (mgadl) and insulin (mUaml), respectively, at the second hour of the OGTT. VD was an estimate of the apparent glucose distribution volume and its value was derived from calculations using a monocompartmental model: VD 150 mlakg of body weight. 24 An additional insulin sensitivity index (SiM) was calculated by averaging Sib and Si2h after balancing Sib by a coef®cient of 0.137 in order to give the same importance to both indexes. The value of the weighing-coef®cient was obtained by calculating the ratio of the mean Si2h to the mean Sib. SiM was ®nally calculated by the following formula:
SiM 0X137 Â Sib Si2ha2
HOMA
Insulin sensitivity was calculated, according to the HOMA, as described by Matthews et al: 21 HOMA Ia22X5 Â e ÀlnG where I and G were obtained before the oral glucose load.
Statistical analysis
Data were analyzed using Statview (version F4.75) for Apple Macintosh. Results are expressed as means AE s.e.m. Comparisons between groups were made by analysis of variance (ANOVA). Within-group comparisons were performed with the paired two-way Student t-test. Correlation coef®cients were used to study the strength of association between measurements of insulin sensitivity. Linear regression was used to evaluate the agreement between determinations of insulin sensitivity derived from the abovede®ned indexes and those derived from the minimal model. Slopes were compared by analysis of covariance as described in Zar. 25 Comparisons between two correlation coef®cients were tested by the use of Z z17z2asz17z2 as described in Zar.
25 P values 0.05 were considered as statistically signi®cant.
Results
Clinical and laboratory characteristics are given in Table 1 . As expected, IGT and type 2 diabetic patients were older and more obese than individuals with normal tolerance to glucose, even though the difference did not reach the threshold of statistical signi®-cance for body mass index (BMI). No major differences were observed between IGT and diabetic patients.
Sib, Si2h and SiM vs minimal model
Si (IVGTT) , Sib, Si2h and SiM were all signi®cantly higher in subjects with NGT than in those with IGT or type 2 diabetes (Table 2 ). However, none of the determinations differed signi®cantly in these two latter groups.
In the 47 patients considered as a whole, Sib, Si2h and SiM were highly correlated with Si (IVGTT) (P`0.0001) (Figure 1 ). When the insulin sensitivity was analyzed separately in the different subsets of 
Insulin, plasma glucose and insulin sensitivity
A Avignon et al patients, Si (IVGTT) was found highly correlated with Sib, Si2h and SiM both in subjects with NGT (r 0.77, r 0.81 and r 0.86, respectively; P`0.0001) and in those with IGT (r 0.95, r 0.91 and r 0.96, respectively; P`0.0001).
In type 2 diabetic patients, a signi®cant correlation was only noted when SiM was tested against Si (IVGTT) : r 0.83, P 0.05. The lack of correlation with the other indexes was probably due to the fact that the number of patients in this group was limited to six. The slopes of correlation lines of SiM against Si (IVGTT) were compared between the three subgroups of subjects: NGT, IGT and overt type 2 diabetes, but no differences were observed (Figure 2 ). Therefore it seems that the relationship between Si (IVGTT) and SiM remains valid over a wide range of glucose tolerance from normal to type 2 diabetes.
Basal insulin (Ib), second hour post oral glucose load insulin (I2h) and HOMA vs minimal model Ib, I2h and HOMA were correlated with Si (IVGTT) in the whole group (r 70.68, r 70.59 and r 70.68, respectively; P 0.0001) as well as in the NGT and IGT subgroups (Table 3) . No signi®cant correlations were observed in the type 2 diabetes subgroup.
Even though the differences did not always reach the level of statistical signi®cance, the correlations of Si (IVGTT) with Ib, I2h or HOMA tended to be weaker than the corresponding correlations with Sib, SI2-hr or SiM (Table 3) .
Considering the group as a whole, the association of Si (IVGTT) with Ib, I2h or HOMA (r 70.68, r 70.59, r 70.68, respectively) was weaker than the association of Si (IVGTT) with SiM (r 0.90; P 0.01). The association of Si (IVGTT) with I2h (r 70.59) was also weaker than the association of Si (IVGTT) with either Sib or SI2h (r 0.83, r 0.83, respectively; P 0.02).
In the subset of patients with NGT, the association of Si (IVGTT) with Ib, I2h or HOMA (r 70.63, r 70.60, r 70.64, respectively) was weaker than the association of Si (IVGTT) with SiM (r 0.89; P 0.05).
In the subset of patients with IGT, correlations of Si (IVGTT) with Ib, I2h or HOMA tended to be weaker than the corresponding associations with SiM, but the comparison of the correlations two by two, did not reach statistical signi®cance. As we have already mentioned, in the type 2 diabetes subgroup, Si (IVGTT) did not correlate with Ib, I2h or HOMA, whereas Si (IVGTT) correlated with SiM (r 0.83; P 0.05).
Discussion
The data of the present work indicate that determinations of the insulin sensitivity by using the minimal model analysis of an insulin-modi®ed FSIVGTT correlate strongly with indexes of insulin sensitivity, as determined by the mathematical product of such simple parameters as plasma glucose and insulin concentrations at fasting andaor at the second hour of an oral glucose loading. As expected, the insulin sensitivity measured either by the indexes, as proposed in the present work, or by the minimal model analysis, was signi®cantly higher in subjects with NGT than in patients with IGT or type 2 diabetes. The differences between the two latter groups were less signi®cant, this ®nding being in agreement with the results of previous studies. 10, 26, 27 The correlation of SiM, with the minimal model determinations of insulin sensitivity was strong both in the group considered as a whole and in each subgroup de®ned from levels of glucose tolerance. In type 2 diabetic patients, the correlation was weaker than in the two other groups when the calculation was made between the minimal model and the index of insulin sensitivity based on measurements of fasting plasma glucose and insulin concentrations (Sib). This might be simply due to the fact that the levels, and therefore the ranges of insulin sensitivity, are markedly reduced in diabetic Insulin, plasma glucose and insulin sensitivity A Avignon et al patients, leading thus to a diminished correlation. This drawback was mostly overcome by using plasma glucose and insulin concentrations at the second hour of an OGTT and by averaging these two parameters with the values obtained at fasting (SiM).
Hence, SiM appears as the most reliable index of insulin sensitivity through the range of glucose tolerance, ranging from normal to type 2 diabetes.
A computer-solved model of insulin : glucose interactions has been developed to estimate b-cell de®-ciency and insulin resistance. 21 However, up to now, this technique called the HOMA analysis has been used only in a few laboratories and the validation remains questionable since wide coef®cients of variation are usually observed. Our results demonstrate that the association of the insulin resistance measured by the minimal model with the HOMA or with a simple measure of plasma insulin either in the basal state or after oral glucose loading is weaker than its association with the indexes used in the present study. Other authors have proposed a fasting insulin resistance index (FIRI) based on basal plasma glucose and insulin. 28 However, this index has never been validated through a wide range of insulin resistance and the value of the results remains questionable, even in NGT subjects. 29 From this, we suggest that the indexes of insulin sensitivity used in the present study (Sib and SiM) and based on the inverse of plasma insulin times plasma glucose levels in the basal state or after an oral glucose load might be a re¯ection of insulin sensitivity per se and as such be used for its evaluation. Therefore the determination could be used routinely by almost every medical center, since the only requirement is a reliable dosage of plasma glucose and insulin. For that reason, it seems reasonable to suggest that in subjects with fasting plasma glucose`110 mgadl (that is, in patients who are expected to be at very low risk of having a two-hour post OGTT glucose concentration b 200 mgadl) 30 Sib could be considered a good index of insulin sensitivity. Only subjects with fasting plasma glucose b 110 mgadl might require an oral glucose load to calculate SiM as an estimate of insulin sensitivity, thus reducing drastically the clinical indication of OGTTs.
Hence, it seems reasonable to postulate from the above considerations that the methods for estimating insulin sensitivity based on plasma glucose and insulin concentrations would be of interest since measurements of insulin sensitivity by either the minimal model or the glucose clamp is not routinely available for every physician. Since it has been reported that in simple obesity, insulin resistance might not be as prevalent as previously thought and is less frequent than insulin hypersecretion, 31 a simple index of insulin sensitivity could be useful in helping the general practitioner to recognize those obese individuals who are insulin resistant and thus at risk for developing type 2 diabetes andaor cardiovascular disease (CVD).
Conclusion
In summary, calculations of sensitivity indexes from plasma glucose and insulin concentrations in the basal state and during a conventional two-hour OGTT provide estimates of insulin sensitivity that correlate signi®cantly with those obtained with the minimal model and the euglycemic hyperinsulinemic clamp. Furthermore, such markers appear to be useful for coupling in the same simple and single test both a determination of glucose tolerance according to the WHO criteria and an estimate of insulin sensitivity. They might prove to be a valuable tool to study insulin resistance and related metabolic complications in such common conditions as obesity.
